Genetic studies continue to strengthen the case for targeting microglia in Alzheimer’s disease. The harder task is ...
Building better biological AI models requires more than simply generating more data. Four initiatives launched or expanded in ...
FDA approved the first plasmid DNA-based immunotherapy in October, granting accelerated approval to Inovio’s Voceryq ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results